TITLE:
Research on Cooperative Benefit Distribution Mechanism of Pharmaceutical Supply Chain with the Participation of Third-Party Logistics Service Providers
AUTHORS:
Lijuan Huang, Yingyu Wu, Lili Liu
KEYWORDS:
Third-Party Logistics Service Providers, Pharmaceutical Supply Chain, Distribution of Cooperation Benefits, Shapley Value Benefit Distribution Method, Profit Distribution Factor
JOURNAL NAME:
Advances in Applied Sociology,
Vol.12 No.2,
February
21,
2022
ABSTRACT: With
the cancellation of the policy of “approval of third-party drug logistics
business”, a large number of powerful enterprises that meet the conditions of
modern pharmaceutical logistics have entered the pharmaceutical logistics. In this context, the introduction of third-party
logistics service providers into the pharmaceutical supply chain system
makes the problem study more practical. A
three-level pharmaceutical supply chain operation mode was constructed, which was composed of pharmaceutical
manufacturers, pharmaceutical distributors, third-party logistics
service providers and retail pharmacies/ hospitals. By using game model, the relevant
indicators under independent decision-making
and cooperative decision-making can be compared and analyzed. The
results show that in a certain range of cooperative cost, the performance index
of pharmaceutical supply chain cooperative decision is significantly higher
than that of independent decision. On this basis, considering two conditions that every supply chain member can
obtain more benefits than that of independent decisions and the relative
leadership of supply chain members, the cooperation benefits of pharmaceutical
supply chain are reasonably distributed by three-distribution method based on
profit distribution factors. Combined with the results, the elements affecting
the profit distribution factor are explored, and the value range of the profit
distribution factor is continuously reduced until the final result is
determined and applied in practice, so as to
ensure the stable cooperative operation of the pharmaceutical supply
chain system.